# OnCo record nct05429632 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05429632/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05429632", "NCT05429632" ;
  schema:name "Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT"@en ;
  schema:alternateName "MO-TRANS"@en ;
  schema:description "A phase 3 trial of mocravimod in acute myeloid leukaemia, run by Priothera SAS, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05429632/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05429632> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2022-06-16" ;
  onco:cancers <https://onco.cc/cancers/aml/> .